180 related articles for article (PubMed ID: 15314485)
21. Recent advances in the biologic therapy of lupus: the 10 most important areas to look for common pitfalls in clinical trials.
Medina-Rosas J; Al-Rayes H; Moustafa AT; Touma Z
Expert Opin Biol Ther; 2016 Oct; 16(10):1225-38. PubMed ID: 27429254
[TBL] [Abstract][Full Text] [Related]
22. Cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in systemic lupus erythematosus.
Trevisani VF; Castro AA; Neves Neto JF; Atallah AN
Cochrane Database Syst Rev; 2000; (3):CD002265. PubMed ID: 10908541
[TBL] [Abstract][Full Text] [Related]
23. Balancing efficacy and toxicity of novel therapies in systemic lupus erythematosus.
Fanouriakis A; Boumpas DT; Bertsias GK
Expert Rev Clin Pharmacol; 2011 Jul; 4(4):437-51. PubMed ID: 22114854
[TBL] [Abstract][Full Text] [Related]
24. Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus.
Bakshi J; Segura BT; Wincup C; Rahman A
Clin Rev Allergy Immunol; 2018 Dec; 55(3):352-367. PubMed ID: 28853005
[TBL] [Abstract][Full Text] [Related]
25. Current role of rituximab in systemic lupus erythematosus.
Mok CC
Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
[TBL] [Abstract][Full Text] [Related]
26. Systematic review, and meta-analysis of steroid-sparing effect, of biologic agents in randomized, placebo-controlled phase 3 trials for systemic lupus erythematosus.
Oon S; Huq M; Godfrey T; Nikpour M
Semin Arthritis Rheum; 2018 Oct; 48(2):221-239. PubMed ID: 29426575
[TBL] [Abstract][Full Text] [Related]
27. Approaches to the management of systemic lupus erythematosus.
Strand V
Curr Opin Rheumatol; 1997 Sep; 9(5):410-20. PubMed ID: 9309196
[TBL] [Abstract][Full Text] [Related]
28. Biological treatments for systemic lupus erythematosus.
Isenberg D; Leckie MJ
Scand J Rheumatol; 2002; 31(4):187-91. PubMed ID: 12369648
[TBL] [Abstract][Full Text] [Related]
29. Biological therapies in the treatment of cutaneous lupus erythematosus.
Presto JK; Hejazi EZ; Werth VP
Lupus; 2017 Feb; 26(2):115-118. PubMed ID: 27687023
[TBL] [Abstract][Full Text] [Related]
30. Treatment of systemic lupus erythematosus.
Miller ML
Curr Opin Rheumatol; 1992 Oct; 4(5):693-9. PubMed ID: 1419504
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of pharmaceutical care for drug treatment adherence in patients with systemic lupus erythematosus in Rio de Janeiro, Brazil: study protocol for a randomized controlled trial.
Oliveira-Santos M; Verani JF; Camacho LA; de Andrade CA; Ferrante-Silva R; Klumb EM
Trials; 2016 Apr; 17():181. PubMed ID: 27038611
[TBL] [Abstract][Full Text] [Related]
32. Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.
Aringer M; Burkhardt H; Burmester GR; Fischer-Betz R; Fleck M; Graninger W; Hiepe F; Jacobi AM; Kötter I; Lakomek HJ; Lorenz HM; Manger B; Schett G; Schmidt RE; Schneider M; Schulze-Koops H; Smolen JS; Specker C; Stoll T; Strangfeld A; Tony HP; Villiger PM; Voll R; Witte T; Dörner T
Lupus; 2012 Apr; 21(4):386-401. PubMed ID: 22072024
[TBL] [Abstract][Full Text] [Related]
33. When biologics should be used in systemic lupus erythematosus?
Gottenberg JE; Lorenzo N; Sordet C; Theulin A; Chatelus E; Sibilia J
Presse Med; 2014 Jun; 43(6 Pt 2):e181-5. PubMed ID: 24933678
[TBL] [Abstract][Full Text] [Related]
34. Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis.
Marks SD; Tullus K
Acta Paediatr; 2010 Jul; 99(7):967-74. PubMed ID: 20222881
[TBL] [Abstract][Full Text] [Related]
35. Upcoming biological therapies in systemic lupus erythematosus.
Sciascia S; Talavera-Garcia E; Roccatello D; Baldovino S; Mengatti E; Cuadrado MJ
Int Immunopharmacol; 2015 Aug; 27(2):189-93. PubMed ID: 26028152
[TBL] [Abstract][Full Text] [Related]
36. Biologics in SLE: the current status.
Rajadhyaksha AG; Mehra S; Nadkar MY
J Assoc Physicians India; 2013 Apr; 61(4):262-7. PubMed ID: 24482965
[TBL] [Abstract][Full Text] [Related]
37. Lessons learned from the failure of several recent trials with biologic treatment in systemic lupus erythematosus.
Hruskova Z; Tesar V
Expert Opin Biol Ther; 2018 Sep; 18(9):989-996. PubMed ID: 30040494
[TBL] [Abstract][Full Text] [Related]
38. [Use of plasmapheresis in therapy of systemic lupus erythematosus: a controlled study].
Zielinski C; Müller C; Smolen J
Acta Med Austriaca; 1988; 15(5):155-8. PubMed ID: 3064527
[TBL] [Abstract][Full Text] [Related]
39. Avoiding diagnostic pitfalls in neuropsychiatric lupus: the importance of attribution.
Hanly JG
Lupus; 2017 Apr; 26(5):497-503. PubMed ID: 28394229
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of recent clinical trials in lupus.
Brooks EB; Liang MH
Curr Opin Rheumatol; 1999 Sep; 11(5):341-7. PubMed ID: 10503652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
